136 related articles for article (PubMed ID: 24975183)
1. Interchangeability between paracetamol tablets marketed in Palestine. Is there a quality reason for a higher price?
Zaid A; Rinno T; Jaradat N; Jodeh S; Khammash S
East Mediterr Health J; 2013 Jun; 19(6):542-6. PubMed ID: 24975183
[TBL] [Abstract][Full Text] [Related]
2. A survey of the quality of generic clarithromycin products from 18 countries.
Nightingale CH
Clin Drug Investig; 2005; 25(2):135-52. PubMed ID: 17523763
[TBL] [Abstract][Full Text] [Related]
3. A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel.
Nightingale CH
Adv Ther; 2000; 17(3):167-78. PubMed ID: 11183454
[TBL] [Abstract][Full Text] [Related]
4. Consumers' Perception of Generic Medicines and Evaluation of In Vitro Quality Control Parameters of Locally Manufactured Paracetamol Tablets in Asmara, Eritrea: A Cross-Sectional Study.
Idris IM; Hassan DN; Hassen HA; Araya RZ; Weldemariam DG
Biomed Res Int; 2021; 2021():6642826. PubMed ID: 34150909
[TBL] [Abstract][Full Text] [Related]
5. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
Babalola CP; Oladimeji FA; Femi-Oyewo MN
Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
[TBL] [Abstract][Full Text] [Related]
6. PHARMACEUTICAL QUALITY OF GENERIC ATORVASTATIN PRODUCTS COMPARED WITH THE INNOVATOR PRODUCT: A NEED FOR REVISING PRICING POLICY IN PALESTINE.
Shawahna R; Hroub AK; Abed E; Jibali S; Al-Saghir R; Zaid AN
Acta Pol Pharm; 2016; 73(3):725-30. PubMed ID: 27476290
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®.
Gasser UE; Fischer A; Timmermans JP; Arnet I
BMC Pharmacol Toxicol; 2013 Apr; 14():24. PubMed ID: 23617953
[TBL] [Abstract][Full Text] [Related]
8. Paracetamol bioavailability study by means of salivary samples.
Nejem RM; Issa MM; Shaat NT
Pak J Biol Sci; 2007 May; 10(9):1553-5. PubMed ID: 19069976
[TBL] [Abstract][Full Text] [Related]
9. "Insight" into drug quality: comparison of simvastatin tablets from the US and Canada obtained via the Internet.
Veronin MA; Lee E; Lewis EN
Ann Pharmacother; 2007 Jul; 41(7):1111-5. PubMed ID: 17595307
[TBL] [Abstract][Full Text] [Related]
10. Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia.
AlSwayeh R; Alvi SN; Hammami MM
BMC Res Notes; 2021 Jun; 14(1):254. PubMed ID: 34193274
[TBL] [Abstract][Full Text] [Related]
11. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
12. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
Walker AD; Adachi JD
Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence study of paracetamol tablets: in vitro-in vivo correlation.
Domínguez A; Medina R; Hurtado M
Drug Dev Ind Pharm; 2000 Aug; 26(8):821-8. PubMed ID: 10900538
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of paracetamol.
Kaojarern S; Sriapa C; Sirivarasai J; Tongpoo A; Thareerach M
J Med Assoc Thai; 1999 Nov; 82(11):1149-53. PubMed ID: 10659551
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical equivalent studies of some commercially available brands of Loratadine hydrochloride tablets.
Adetunji OA; Adigun NF; Odeniyi MA
Afr J Med Med Sci; 2015 Sep; 44(3):269-76. PubMed ID: 27280240
[TBL] [Abstract][Full Text] [Related]
17. Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the US.
Fisher AC; Viehmann A; Ashtiani M; Friedman RL; Buhse L; Kopcha M; Woodcock J
JAMA Netw Open; 2020 Aug; 3(8):e2013920. PubMed ID: 32833019
[TBL] [Abstract][Full Text] [Related]
18. Controlling individual steps in the production process of paracetamol tablets by use of NIR spectroscopy.
Blanco M; Cueva-Mestanza R; Peguero A
J Pharm Biomed Anal; 2010 Mar; 51(4):797-804. PubMed ID: 19880266
[TBL] [Abstract][Full Text] [Related]
19. Quality performance of metronidazole tablet products on the Kenyan market.
Kibwage IO; Thuranira J; Migosi D
East Afr Med J; 1991 May; 68(5):365-71. PubMed ID: 1935731
[TBL] [Abstract][Full Text] [Related]
20. Economic and technological drivers of generic sterile injectable drug shortages.
Woodcock J; Wosinska M
Clin Pharmacol Ther; 2013 Feb; 93(2):170-6. PubMed ID: 23337525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
